India's Pharma Wars
The Swiss pharmaceutical giant Novartis and German drug maker Bayer are challenging the Indian establishment over the country’s drug-patent rules, an affair that frames the larger confrontation between the global pharmaceutical industry and the governments of the emerging economies.
With pharmaceutical sales growth slowing in the West, multinationals are…
Keep reading with a 7-day free trial
Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.